MedPath

Study on glycemic control, weight, body fat and insulin resistance in SGLT2 inhibitor-treated Japanese patients

Not Applicable
Conditions
Type 2 diabetes
Registration Number
JPRN-UMIN000016635
Lead Sponsor
Medical Corporation H.E.C Science Clinic
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Extreme low carbohydrate therapy practitioner. Considered as inappropriate by the attending physician. A person who falls under contraindication in the medical package insert.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HbA1c ,FPG ,Body weight ,Body mass index ,Body fat
Secondary Outcome Measures
NameTimeMethod
Visceral fat area ,Waist circumference ,Amount of body fat distribution ,Lean body weight ,HOMA-IR ,HOMA-b ,iHOMA2 ,Blood pressure ,Lipid ,Uric acid ,eGFR ,GIR ,Liver function ,Renal function ,Adiponectin ,TNFa ,IL-6 ,NTpro-BNP
© Copyright 2025. All Rights Reserved by MedPath